IDEAYA Biosciences Inc banner

Company Overview

Business Description

Sector
Health Care
Industry
Biotechnology
Headquarters
United States of America US
Employees
145
IPO date
May 23, 2019

IDEAYA Biosciences is a biotechnology company that develops cancer drugs aimed at tumors with specific genetic weaknesses. Its work focuses on precision oncology, especially small-molecule medicines designed to block the pathways cancer cells depend on while sparing healthier cells. The company’s main assets are its drug candidates and the science behind matching the right drug to the right tumor type.

IDEAYA does not sell consumer products. It makes money mainly through collaboration deals with larger pharmaceutical companies, plus licensing payments, research funding, milestone payments, and potential royalties if partnered drugs succeed. If its own programs reach the market, it could also earn direct drug sales revenue, but today it is primarily a drug developer rather than a commercial seller.

What makes IDEAYA’s business different is its focus on synthetic lethality and other biomarker-driven cancer targets. Instead of trying to treat all cancers the same way, it builds medicines for patients whose tumors carry certain mutations or vulnerabilities. That places the company in the high-risk, high-reward part of biotech, where scientific validation and partner relationships are central to the business model.

IDEAYA Biosciences Inc Investor Relations

Address
7000 Shoreline Ct, Suite 350
South San Francisco, California
United States of America

Business Segments

Drug development

IDEAYA discovers and develops targeted medicines for cancer, then moves the best programs through testing in patients. It focuses on small-molecule drugs and other precision oncology treatments.

Customers and revenue model

Partnerships

IDEAYA also works with larger drug companies on selected programs and research efforts, sharing know-how and assets to advance cancer drug candidates.

Customers and revenue model

Management

Mr. Yujiro S. Hata

President, CEO & Director

Biography unavailable

Dr. Michael A. White Ph.D.

Chief Scientific Officer

Biography unavailable

Dr. Darrin M. Beaupre M.D., Ph.D.

Chief Medical Officer

Biography unavailable

Dr. Paul A. Barsanti Ph.D.

Chief Technology Officer

Biography unavailable

Mr. Douglas B. Snyder

Senior VP & General Counsel

Biography unavailable

Ms. Francine Zelaya

Vice President & Head of Human Resources

Biography unavailable

Mr. Mick O'Quigley

Chief of Staff & Clinical Development

Biography unavailable

Mr. Daniel A. Simon

Chief Business Officer

Biography unavailable

Mr. Stu Dorman

Chief Commercial Officer

Biography unavailable

1 / 9